Myriad Genetics Inc (MYGN)
15.12
-0.18
(-1.18%)
USD |
NASDAQ |
Nov 21, 16:00
15.12
0.00 (0.00%)
After-Hours: 20:00
Myriad Genetics Total Assets (Quarterly): 1.081B for Sept. 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 1.081B |
June 30, 2024 | 1.085B |
March 31, 2024 | 1.110B |
December 31, 2023 | 1.146B |
September 30, 2023 | 1.149B |
June 30, 2023 | 1.187B |
March 31, 2023 | 1.169B |
December 31, 2022 | 1.199B |
September 30, 2022 | 1.212B |
June 30, 2022 | 1.210B |
March 31, 2022 | 1.255B |
December 31, 2021 | 1.321B |
September 30, 2021 | 1.336B |
June 30, 2021 | 1.360B |
March 31, 2021 | 1.337B |
September 30, 2020 | 1.444B |
June 30, 2020 | 1.405B |
March 31, 2020 | 1.447B |
December 31, 2019 | 1.578B |
September 30, 2019 | 1.591B |
June 30, 2019 | 1.563B |
March 31, 2019 | 1.557B |
December 31, 2018 | 1.557B |
September 30, 2018 | 1.574B |
June 30, 2018 | 1.175B |
Date | Value |
---|---|
March 31, 2018 | 1.218B |
December 31, 2017 | 1.228B |
September 30, 2017 | 1.228B |
June 30, 2017 | 1.209B |
March 31, 2017 | 1.268B |
December 31, 2016 | 1.276B |
September 30, 2016 | 1.271B |
June 30, 2016 | 880.50M |
March 31, 2016 | 868.20M |
December 31, 2015 | 871.70M |
September 30, 2015 | 787.00M |
June 30, 2015 | 766.20M |
March 31, 2015 | 779.05M |
December 31, 2014 | 781.85M |
September 30, 2014 | 809.01M |
June 30, 2014 | 823.80M |
March 31, 2014 | 816.43M |
December 31, 2013 | 756.68M |
September 30, 2013 | 781.66M |
June 30, 2013 | 803.82M |
March 31, 2013 | 729.03M |
December 31, 2012 | 717.75M |
September 30, 2012 | 703.06M |
June 30, 2012 | 690.64M |
March 31, 2012 | 699.25M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
1.081B
Minimum
Sep 2024
1.578B
Maximum
Dec 2019
1.265B
Average
1.212B
Median
Sep 2022
Total Assets (Quarterly) Benchmarks
Boston Scientific Corp | 38.08B |
ResMed Inc | 7.222B |
Globus Medical Inc | 5.086B |
Perspective Therapeutics Inc | 391.15M |
Electromed Inc | 48.92M |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 349.60M |
Shareholders Equity (Quarterly) | 731.70M |
Debt to Equity Ratio | 0.0533 |
Current Ratio | 1.900 |
Net Debt Paydown Yield | -0.00% |